Sustaining Vaccine Confidence in the 21st Century

被引:24
|
作者
Hardt, Karin [1 ]
Schmidt-Ott, Ruprecht [2 ]
Glismann, Steffen [3 ]
Adegbola, Richard A. [1 ]
Meurice, Francois P. [1 ]
机构
[1] GlaxoSmithKline Vaccines, Global Sci Affairs & Med Educ, 20 Ave Fleming, B-1300 Wavre, Belgium
[2] GlaxoSmithKline Vaccines, Global Sci Affairs & Med Educ, D-81675 Munich, Germany
[3] GlaxoSmithKline Vaccines, Global Sci Affairs & Med Educ, DK-2605 Brondby, Denmark
来源
VACCINES | 2013年 / 1卷 / 03期
关键词
vaccine safety; vaccine confidence; vaccine hesitancy; public health; immunization; coverage; pharmaceutical industry;
D O I
10.3390/vaccines1030204
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination provides many health and economic benefits to individuals and society, and public support for immunization programs is generally high. However, the benefits of vaccines are often not fully valued when public discussions on vaccine safety, quality or efficacy arise, and the spread of misinformation via the internet and other media has the potential to undermine immunization programs. Factors associated with improved public confidence in vaccines include evidence-based decision-making procedures and recommendations, controlled processes for licensing and monitoring vaccine safety and effectiveness and disease surveillance. Community engagement with appropriate communication approaches for each audience is a key factor in building trust in vaccines. Vaccine safety/quality issues should be handled rapidly and transparently by informing and involving those most affected and those concerned with public health in effective ways. Openness and transparency in the exchange of information between industry and other stakeholders is also important. To maximize the safety of vaccines, and thus sustain trust in vaccines, partnerships are needed between public health sector stakeholders. Vaccine confidence can be improved through collaborations that ensure high vaccine uptake rates and that inform the public and other stakeholders of the benefits of vaccines and how vaccine safety is constantly assessed, assured and communicated.
引用
收藏
页码:204 / 224
页数:21
相关论文
共 50 条
  • [21] Into the 21st century
    Marschark, Marc
    JOURNAL OF DEAF STUDIES AND DEAF EDUCATION, 2007, 12 (02): : 125 - 126
  • [22] Challenges and Opportunities for Bacterial Vaccine Development in the 21st Century
    Duvvuri, Venkata R.
    Barreto, Luis
    Wu, Jianhong
    Tsang, Raymond S. W.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2013, 14 (08) : 758 - 767
  • [23] Into the 21st century
    Anon
    Paper Europe, 1999, 11 (03):
  • [24] Into the 21St century
    Carr, SV
    Delvin, D
    Hannaford, P
    Kubba, A
    McEwan, J
    O'Brien, P
    Surti, NB
    Dempster, K
    Monger, S
    Carter, R
    BRITISH JOURNAL OF FAMILY PLANNING, 1999, 25 (03): : 87 - 89
  • [25] Into the 21st century
    Holmes, Mary
    Manning, Nathan
    Wettergren, Asa
    EMOTIONS AND SOCIETY, 2019, 1 (01): : 3 - 8
  • [26] Vaccine development in the 21st century: A time of living dangerously
    Vordermeier, M
    Hogarth, P
    VETERINARY JOURNAL, 2005, 170 (03): : 271 - 272
  • [27] A second vaccine revolution for the new epidemics of the 21st century
    Dyer, Mark R.
    Renner, Wolfgang A.
    Bachmann, Martin F.
    DRUG DISCOVERY TODAY, 2006, 11 (21-22) : 1028 - 1033
  • [28] OVERCOMING ROUTINE: A 21ST CENTURY SKILL FOR A 21ST CENTURY ECONOMY
    Strunz, Ulrich
    Chlupsa, Christian
    INTERNATIONAL JOURNAL OF ECONOMIC SCIENCES, 2019, 8 (02): : 109 - 126
  • [29] The Expert Library: Staffing, Sustaining, and Advancing the Academic Library in the 21st Century
    Montgomery, Susan
    LIBRARY JOURNAL, 2011, 136 (02) : 74 - 74